The revenue stands at ₹7,047.51 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.43 per cent from ₹6,268.34 crore. This corresponds to a year-on-year *(YoY) growth of 24.23 per cent.
Operating Profit stands at ₹197.59 crore, reflecting a quarter-on-quarter *(QoQ) increase of 15.69 per cent from ₹170.80 crore. This corresponds to a year-on-year *(YoY) growth of 74.61 per cent.
PBDT stands at ₹838.91 crore, reflecting a quarter-on-quarter *(QoQ) increase of 70.14 per cent from ₹493.06 crore. This corresponds to a year-on-year *(YoY) growth of 85.48 per cent.
Profit Before Tax stands at ₹2,006.97 crore, reflecting a quarter-on-quarter *(QoQ) increase of 41.78 per cent from ₹1,415.54 crore. This corresponds to a year-on-year *(YoY) growth of 90.26 per cent.
Net Profit stands at ₹1,477.92 crore, reflecting a quarter-on-quarter *(QoQ) increase of 21.24 per cent from ₹1,219.03 crore. This represents a 73.34 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Lupin | -0.37% | -0.68% | 0.58% | 8.18% | 13.30% | 8.76% |
| Torrent Pharma. | 1.89% | 2.53% | 3.18% | 6.57% | 12.28% | 32.99% |
| Cipla | -0.03% | 0.71% | -8.45% | -11.70% | -11.74% | -7.43% |
| Dr Reddy's Labs | -1.19% | 0.96% | 3.41% | 2.27% | 2.99% | 3.39% |
| Zydus Lifesci. | -3.64% | -2.00% | -0.89% | -6.75% | -7.23% | -5.05% |
| Mankind Pharma | -0.56% | -0.37% | -6.83% | -8.73% | -14.65% | -14.31% |
| Alkem Lab | 1.19% | 2.46% | -1.14% | 0.63% | 12.64% | 23.21% |
Chairman (Non-Executive) : M D Gupta
Managing Director : Nilesh Deshbandhu Gupta.
Director & Chief Executive Officer : Vinita Gupta
Company Sec. & Compli. Officer : R V Satam
Independent Director : Jean-Luc Belingard
Director & Group CFO : Ramesh Swaminathan
Independent Director : Mark D McDade
Independent Director : K B S Anand
Independent Director : Jeffrey Kindler
Independent Director : Alfonso Zulueta
Independent Director : Punita Lal